Arkolith/Insider Trading/CLSD/Form 4/A

Deignan Charles A.

Chief Financial OfficerClearside Biomedical, Inc. (CLSD) · full profile →Form 4/A · filed Jan 28, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 18, 2022Grant(A)46K—$0363K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 18, 2022Grant(A)139K—$0139K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001209191-22-005437) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML